Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early-Phase Open-label Study of Tolinapant and Radiation in Cisplatin-Ineligible Patients With Previously Untreated, Locally Advanced Head and Neck Cancer

NCT05245682 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05245682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05245682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early-Phase Open-label Study of Tolinapant and Radiation in Cisplatin-Ineligible Patients With Previously Untreated, Locally Advanced Head and Neck Cancer
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 17, 2022
Completion date
July 21, 2027
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck carcinoma of unknown primary, locally advanced head and neck squamous cell carcinoma, locally advanced hypopharyngeal squamous cell carcinoma, locally advanced laryngeal squamous cell carcinoma, locally advanced nasopharyngeal squamous cell carcinoma, locally advanced oropharyngeal squamous cell carcinoma